Synthetic neurosteroids on brain protection

Area of Science:

• Neuroscience and Pharmacology
• Medicinal Chemistry

Background:

• Neurosteroids, such as allopregnanolone and pregnanolone, are endogenous modulators of neuronal excitability.
• They exhibit potent and selective activity at GABAA receptors, conferring anticonvulsant, anesthetic, and anxiolytic properties.
• Current therapeutic applications for neurological and psychiatric disorders are limited by rapid metabolism and low oral bioavailability of endogenous neurosteroids.

Purpose of the Study:

• To explore synthetic steroid analogues as potential therapeutic agents for neurological and psychiatric disorders.
• To review the properties and neurosteroid-like actions of various synthetic steroids developed and tested.
• To highlight strategies for enhancing stability and bioavailability compared to endogenous neurosteroids.

Main Methods:

• Analysis of existing literature on synthetic steroids with neurosteroid-like effects.
• Examination of structure-activity relationships, focusing on the critical 3α-hydroxyl configuration.
• Review of modifications in the steroid nucleus to identify key pharmacophores.

Main Results:

• Several synthetic steroids have demonstrated successful neurosteroid-like effects in preclinical or clinical investigations.
• Modifications to the steroid nucleus can influence pharmacophore activity and receptor binding.
• Synthetic analogues offer potential advantages in terms of metabolic stability and oral bioavailability.

Conclusions:

• Synthetic neurosteroids represent a promising therapeutic strategy for neurological and psychiatric conditions.
• Targeted modifications of steroid structures can yield compounds with enhanced pharmacological profiles.
• Further development of these synthetic analogues may lead to improved treatments with reduced side effects.